Cargando…

Neuropsychological Decline Improves Prediction of Dementia Beyond Alzheimer’s Disease Biomarker and Mild Cognitive Impairment Diagnoses

BACKGROUND: A clinical diagnosis of cognitive impairment is traditionally based on a single cognitive exam, but serial cognitive testing can be sensitive to subtle cognitive changes in asymptomatic individuals and inform cognitive trajectory. OBJECTIVE: We evaluated the prognostic utility of identif...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nation, Daniel A., Ho, Jean K., Dutt, Shubir, Han, S. Duke, Lai, Mark H.C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	IOS Press 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6598015/ https://www.ncbi.nlm.nih.gov/pubmed/31104015 http://dx.doi.org/10.3233/JAD-180525

Ejemplares similares

Neuropsychological Decline Stratifies Dementia Risk in Cognitively Unimpaired and Impaired Older Adults
por: Ho, Jean K., et al.
Publicado: (2022)

P300 and Neuropsychological Assessment in Mild Cognitive Impairment and Alzheimer Dementia
por: Parra, Mario A., et al.
Publicado: (2012)

Brainstem substructures and cognition in prodromal Alzheimer’s disease
por: Dutt, Shubir, et al.
Publicado: (2021)

Neuropsychological Evaluation and Quantitative EEG in Patients with Frontotemporal Dementia, Alzheimer’s Disease, and Mild Cognitive Impairment
por: Tomasello, Letteria, et al.
Publicado: (2023)

Neuropsychological Profiles in Mild Cognitive Impairment due to Alzheimer’s and Parkinson’s Diseases
por: Hessen, Erik, et al.
Publicado: (2016)

Neuropsychological predictors of conversion from mild cognitive impairment to dementia at different timepoints
por: Quaranta, Davide, et al.
Publicado: (2023)

Prediction of Cognitive Decline in Temporal Lobe Epilepsy and Mild Cognitive Impairment by EEG, MRI, and Neuropsychology
por: Höller, Yvonne, et al.
Publicado: (2020)

Leukotriene receptor antagonist use and cognitive decline in normal cognition, mild cognitive impairment, and Alzheimer’s dementia
por: Xiong, Lisa Y., et al.
Publicado: (2021)

Neuropsychological methods in mild cognitive impairment
por: Hahn-Barma, Valérie, et al.
Publicado: (2004)

Factors Predicting the Onset of Amnestic Mild Cognitive Impairment or Alzheimer’s Dementia in Persons With Subjective Cognitive Decline
por: Ahn, Sangwoo, et al.
Publicado: (2020)

Beyond mild cognitive impairment: vascular cognitive impairment, no dementia (VCIND)
por: Stephan, Blossom CM, et al.
Publicado: (2009)

Resting state EEG biomarkers of cognitive decline associated with Alzheimer’s disease and mild cognitive impairment
por: Meghdadi, Amir H., et al.
Publicado: (2021)

Plasma biomarkers for diagnosis of Alzheimer's disease and prediction of cognitive decline in individuals with mild cognitive impairment
por: Kivisäkk, Pia, et al.
Publicado: (2023)

Advances in diagnosing mild cognitive impairment and Alzheimer’s disease using (11)C-PIB- PET/CT and common neuropsychological tests
por: Zhao, Qing, et al.
Publicado: (2023)

Cognitive Blackouts in Mild Cognitive Impairment and Alzheimer's Dementia
por: Adler, Georg, et al.
Publicado: (2018)

Patterns of Cognitive Decline Prior to Dementia in Persons with Mild Cognitive Impairment
por: Cloutier, Simon, et al.
Publicado: (2015)

Trajectories of subjective cognitive decline, and the risk of mild cognitive impairment and dementia
por: Liew, Tau Ming
Publicado: (2020)

Comparison of performance in neuropsychological tests in amnestic Mild Cognitive Impairment and Alzheimer’s disease patients
por: do Vale, Patrícia Helena Figueirêdo, et al.
Publicado: (2009)

Machine Learning Decomposition of the Anatomy of Neuropsychological Deficit in Alzheimer’s Disease and Mild Cognitive Impairment
por: Dong, Ningxin, et al.
Publicado: (2022)

Retention and impairment of neurocognitive functions in mild cognitive impairment and Alzheimer’s disease with a comprehensive neuropsychological test
por: Yao, Lu, et al.
Publicado: (2022)

Disproportionate Decline of Executive Functions in Early Mild Cognitive Impairment, Late Mild Cognitive Impairment, and Mild Alzheimer's Disease
por: Kim, Sangsoon, et al.
Publicado: (2016)

Incremental value of biomarker combinations to predict progression of mild cognitive impairment to Alzheimer’s dementia
por: Frölich, Lutz, et al.
Publicado: (2017)

Increased prediction value of biomarker combinations for the conversion of mild cognitive impairment to Alzheimer’s dementia
por: Zhao, Aonan, et al.
Publicado: (2020)

Biomarkers in subtypes of mild cognitive impairment and subjective cognitive decline
por: Eliassen, Carl F., et al.
Publicado: (2017)

Subjective cognitive decline, anxiety symptoms, and the risk of mild cognitive impairment and dementia
por: Liew, Tau Ming
Publicado: (2020)

Psychological stress, cognitive decline and the development of dementia in amnestic mild cognitive impairment
por: Sussams, Rebecca, et al.
Publicado: (2020)

Visit-to-Visit Blood Pressure Variability and CSF Alzheimer Disease Biomarkers in Cognitively Unimpaired and Mildly Impaired Older Adults
por: Sible, Isabel J., et al.
Publicado: (2022)

Mild cognitive impairment in adult: A neuropsychological review
por: Yanhong, Ouyang, et al.
Publicado: (2013)

Neuropsychological Measures that Predict Progression from Mild Cognitive Impairment to Alzheimer's type dementia in Older Adults: a Systematic Review and Meta-Analysis
por: Belleville, Sylvie, et al.
Publicado: (2017)

Consensus statement on the neurocognitive outcomes for early detection of mild cognitive impairment and Alzheimer dementia from the Chinese Neuropsychological Normative (CN-NORM) Project
por: Wang, Huali, et al.
Publicado: (2019)

Evidence for the Utility of Actuarial Neuropsychological Criteria Across the Continuum of Normal Aging, Mild Cognitive Impairment, and Dementia
por: Graves, Lisa V., et al.
Publicado: (2020)

Plasma neurofilament light chain as a biomarker of Alzheimer’s disease in Subjective Cognitive Decline and Mild Cognitive Impairment
por: Giacomucci, Giulia, et al.
Publicado: (2022)

Telomere shortening reflecting physical aging is associated with cognitive decline and dementia conversion in mild cognitive impairment due to Alzheimer’s disease
por: Koh, Seong-Ho, et al.
Publicado: (2020)

The relative importance of imaging markers for the prediction of Alzheimer's disease dementia in mild cognitive impairment — Beyond classical regression
por: Teipel, Stefan J., et al.
Publicado: (2015)

In Brief Neuropsychological Assessment, Amnestic Mild Cognitive Impairment (MCI) Is associated with Cerebrospinal Fluid Biomarkers for Cognitive Decline in Contrast to the Prevailing NIA-AA MCI Criterion
por: Hessen, Erik, et al.
Publicado: (2019)

Baseline Neuroimaging Predicts Decline to Dementia From Amnestic Mild Cognitive Impairment
por: Gullett, Joseph M., et al.
Publicado: (2021)

Plasma biomarkers for prognosis of cognitive decline in patients with mild cognitive impairment
por: Kivisäkk, Pia, et al.
Publicado: (2022)

Distilling Heterogeneity of Mild Cognitive Impairment in the National Alzheimer Coordinating Center Database Using Latent Profile Analysis
por: Blanken, Anna E., et al.
Publicado: (2020)

Blood Pressure in Different Dementia Disorders, Mild Cognitive Impairment, and Subjective Cognitive Decline
por: Hestad, Knut, et al.
Publicado: (2020)

Inclusion of Neuropsychological Scores in Atrophy Models Improves Diagnostic Classification of Alzheimer's Disease and Mild Cognitive Impairment
por: Goryawala, Mohammed, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_qrdruuvpoddc23tagdp6jh70ld